Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Scripps Translational Science Institute
With
Sapient Bioanalytics
TEAL Rise
23andMe, Inc.
Alamar Biosciences
Oura Ring, Inc
Age
60–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Current 23andMe Research participant with APOE4 positivity genetic variant
Age 60 to 80 at time of consent
Have access to an Android or Apple iPhone smartphone device and able to download study apps
Lives in the United States and able to send and receive US Mail
Able and willing to perform a self-administered saliva test at screening\*for organic outreach only.
Able and willing to perform a self-administered finger prick blood collection at three time points throughout the study.
You may not be if
Non-English speaking
Lives outside of the United States
Currently taking or planning on taking GLP-1 medications (Exenatide, Liraglutide, Albiglutide, Dulaglutide, Semaglutide or Tirzepatide) within the next 12 months
Established diagnosis of Mild Cognitive Impairment, Alzheimer's Disease or other Neurodegenerative Disease (Parkinson's Disease, Amyotrophic Lateral Sclerosis, Huntington's Disease, Multiple Sclerosis or Frontotemporal Dementia).
Current or past Oura Ring user (any Oura Ring use in the last 12 months)
Clareo Health | Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers
